Feb 01, 2013, 08.24 AM | Source: Moneycontrol.com
On January 31, 2013 Serum Institute of India Limit bought 308,416 shares of Panacea Biotec at Rs 120.49 on the NSE.
In the previous trading session, the share closed at Rs 133.95, up Rs 19.10, or 16.63%. It touched an intraday high of Rs 137.80 and an intraday low of Rs 113.20.
The share touched its 52-week high Rs 149.75 and 52-week low Rs 63.50 on 17 September, 2012 and 04 June, 2012, respectively. Currently, it is trading 10.55% below its 52-week high and 110.94% above its 52-week low. Market capitalisation stands at Rs 820.45 crore.
Emmessar Biotec standalone Dec '15 sales at Rs 0.16 crore
Emmessar Biotech And Nutrition has reported a sale
BSE Institute announces launch of new zone for startups
BSE Institute Ltd, a wholly owned subsidiary of BS
GSFC univ, MGLI sign MoU to set up skill development institute
The Memorandum of Understanding was signed by GSFC
RBI chief Rajan meets financial institutions over bad loans
India's banks are grappling with more than USD 110
NITI Aayog, IDFC Institute to conduct survey on ease of biz
NITI Aayog and IDFC Institute will jointly conduct
BSE brings institutional investors under self-trade checks
Top stock exchange BSE has decided to implement se